162
Views
42
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Serum Vascular Endothelial Growth Factor (VEGF) and Interleukin-8 (IL-8) Levels in Small Cell Lung Cancer

, M.D., , Ph.D., , Ph.D., , M.D., , Ph.D. & , M.D.
Pages 492-496 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Daye Cheng, Hong Kong & Yunhui Li. (2013) Prognostic values of VEGF and IL-8 in malignant pleural effusion in patients with lung cancer. Biomarkers 18:5, pages 386-390.
Read now

Articles from other publishers (41)

Jing Yuan, Feng Cheng, Guodong Xiao, Xiaofeng Wang & Huijie Fan. (2022) Efficacy and Safety of Anlotinib in the Treatment of Small Cell Lung Cancer: A Real-World Observation Study. Frontiers in Oncology 12.
Crossref
Emilio Francesco Giunta, Alfredo Addeo, Alessio Rizzo & Giuseppe Luigi Banna. (2022) First-Line Treatment for Advanced SCLC: What Is Left Behind and Beyond Chemoimmunotherapy. Frontiers in Medicine 9.
Crossref
Jenying Deng & Jason B. Fleming. (2022) Inflammation and Myeloid Cells in Cancer Progression and Metastasis. Frontiers in Cell and Developmental Biology 9.
Crossref
Narongchai Autsavapromporn, Pitchayaponne Klunklin, Imjai Chitapanarux, Churdsak Jaikang, Busyamas Chewaskulyong, Patumrat Sripan, Masahiro Hosoda & Shinji Tokonami. (2021) A Potential Serum Biomarker for Screening Lung Cancer Risk in High Level Environmental Radon Areas: A Pilot Study. Life 11:11, pages 1273.
Crossref
Jane Cullis, Shipra Das & Dafna Bar-Sagi. (2018) Kras and Tumor Immunity: Friend or Foe?. Cold Spring Harbor Perspectives in Medicine 8:9, pages a031849.
Crossref
F Koinis, S Agelaki, V Karavassilis, N Kentepozidis, E Samantas, S Peroukidis, P Katsaounis, E Hartabilas, I I Varthalitis, I Messaritakis, G Fountzilas, V Georgoulias & A Kotsakis. (2017) Second-line pazopanib in patients with relapsed and refractory small-cell lung cancer: a multicentre phase II study of the Hellenic Oncology Research Group. British Journal of Cancer 117:1, pages 8-14.
Crossref
Jaromír Kotyza. (2017) Chemokines in tumor proximal fluids. Biomedical Papers 161:1, pages 41-49.
Crossref
Qing Li, Tao Wu, Li Jing, Miao-Jing Li, Tao Tian, Zhi-Ping Ruan, Xuan Liang, Ke-Jun Nan, Zhi-Yan Liu, Yu Yao & Hui Guo. (2017) Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC). Medicine 96:13, pages e6412.
Crossref
Qian Liu, Anping Li, Yijun Tian, Jennifer D. Wu, Yu Liu, Tengfei Li, Yuan Chen, Xinwei Han & Kongming Wu. (2016) The CXCL8-CXCR1/2 pathways in cancer. Cytokine & Growth Factor Reviews 31, pages 61-71.
Crossref
Bryan J. Schneider & Gregory P. Kalemkerian. 2016. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management 149 174 .
Qunying Lin, Lei Xue, Tian Tian, Bo Zhang, Lijing Guo, Guosheng Lin, Zhiwei Chen, Kexing Fan & Xiaobin Gu. (2015) Prognostic Value of Serum IL-17 and VEGF Levels in Small Cell Lung Cancer. The International Journal of Biological Markers 30:4, pages 359-363.
Crossref
Miguel F. Sanmamed, Omar Carranza-Rua, Carlos Alfaro, Carmen Oñate, Salvador Martín-Algarra, Guiomar Perez, Sara F. Landazuri, Álvaro Gonzalez, Stefanie Gross, Inmaculada Rodriguez, Cecilia Muñoz-Calleja, María Rodríguez-Ruiz, Bruno Sangro, José M. López-Picazo, Manglio Rizzo, Guillermo Mazzolini, Juan I. Pascual, Maria Pilar Andueza, Jose Luis Perez-Gracia & Ignacio Melero. (2014) Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins. Clinical Cancer Research 20:22, pages 5697-5707.
Crossref
Nobuhiro Asai, Yoshihiro Ohkuni, Norihiro Kaneko, Etsuro Yamaguchi & Akihito Kubo. (2014) Relapsed small cell lung cancer: treatment options and latest developments. Therapeutic Advances in Medical Oncology 6:2, pages 69-82.
Crossref
C.-C. Lin, C.-Y. Liu, M.-J. Chen, T.-E. Wang, C.-H. Chu, H.-Y. Wang, S.-C. Shih, M.-L. Hsu, T.-C. Hsu & Y.-J. Chen. (2013) Profiles of circulating endothelial cells and serum cytokines during adjuvant chemoradiation in rectal cancer patients. Clinical and Translational Oncology 15:10, pages 855-860.
Crossref
Ji-Youn Han, Hyae Young Kim, Kun Young Lim, Jong Hee Han, You Jin Lee, Mi Hyang Kwak, Hak Jin Kim, Tak Yun, Heung Tae Kim & Jin Soo Lee. (2013) A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer 79:2, pages 137-142.
Crossref
R. M. Mroz, M. Korniluk, B. Panek, M. Ossolinska & E. Chyczewska. 2013. Respiratory Regulation - The Molecular Approach. Respiratory Regulation - The Molecular Approach 313 319 .
Sarmistha Talukdar & Subhas C. Kundu. (2012) A Non-Mulberry Silk Fibroin Protein Based 3D In Vitro Tumor Model for Evaluation of Anticancer Drug Activity. Advanced Functional Materials 22:22, pages 4778-4788.
Crossref
Jaromír Kotyza. (2018) Interleukin-8 (CXCL8) in Tumor Associated Non-Vascular Extracellular Fluids: Its Diagnostic and Prognostic Values. A Review. The International Journal of Biological Markers 27:3, pages 169-178.
Crossref
R J Young, A W Tin, N J Brown, M Jitlal, S M Lee & P J Woll. (2012) Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide. British Journal of Cancer 106:6, pages 1153-1159.
Crossref
Chunxia Su, Caicun Zhou, Songwen Zhou & Jianfang Xu. (2010) Serum cytokine levels in patients with advanced non-small cell lung cancer: correlation with treatment response and survival. Medical Oncology 28:4, pages 1453-1457.
Crossref
Barbora Orlikova, Deniz Tasdemir, Frantisek Golais, Mario Dicato & Marc Diederich. (2011) The aromatic ketone 4′-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition. Biochemical Pharmacology 82:6, pages 620-631.
Crossref
Bryan J. Schneider, Shirish M. Gadgeel, Nithya Ramnath, Antoinette J. Wozniak, Grace K. Dy, Stephanie Daignault & Gregory P. Kalemkerian. (2011) Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer. Journal of Thoracic Oncology 6:6, pages 1117-1120.
Crossref
Jens Schittenhelm, Perikles Simon, Patrick N Harter, Cornelia Zachskorn, Holger Schlaszus, Frauke R?ttger, Monika Winkels, Michael Weller, Richard Meyermann & Michel Mittelbronn. (2011) CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms. Histopathology 58:5, pages 739-749.
Crossref
Sachin Kumar, Randeep Guleria, Vikas Singh, Alok C Bharti, Anant Mohan & Bhudev C Das. (2009) Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer. BMC Cancer 9:1.
Crossref
Krisztina Bogos, Ferenc Renyi-Vamos, Judit Dobos, Jozsef Tovari, Gyula Ostoros & Balazs Dome. (2009) Reply. Clinical Cancer Research 15:21, pages 6740-6741.
Crossref
Anoor Paripati, Chris Kingsley & Glen J. Weiss. (2009) Pathway Targets to Explore in the Treatment of Small Cell and Large Cell Lung Cancers. Journal of Thoracic Oncology 4:11, pages 1313-1321.
Crossref
Kevin M. O'Hayer, Donita C. Brady & Christopher M. Counter. (2009) ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis. Carcinogenesis 30:11, pages 1841-1847.
Crossref
Ulrich Grandel, Diana Heygster, Ulf Sibelius, Ludger Fink, Stefanie Sigel, Werner Seeger, Friedrich Grimminger & Katja Hattar. (2009) Amplification of Lipopolysaccharide-Induced Cytokine Synthesis in Non–Small Cell Lung Cancer/Neutrophil Cocultures. Molecular Cancer Research 7:10, pages 1729-1735.
Crossref
I-Lin Hsu, Wu-Chou Su, Jing-Jou Yan, Jia-Ming Chang & Wu-Wei Lai. (2009) Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: Correlations with patient survival and pleural effusion control. Lung Cancer 65:3, pages 371-376.
Crossref
Rita Rotondo, Gaia Barisione, Luca Mastracci, Francesco Grossi, Anna Maria Orengo, Roberta Costa, Mauro Truini, Marina Fabbi, Silvano Ferrini & Ottavia Barbieri. (2009) IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. International Journal of Cancer 125:4, pages 887-893.
Crossref
Siow Ming Lee, Penella J. Woll, Robin Rudd, David Ferry, Mary O'Brien, Gary Middleton, Stephen Spiro, Lindsay James, Kulsam Ali, Mark Jitlal & Allan Hackshaw. (2009) Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial. JNCI: Journal of the National Cancer Institute 101:15, pages 1049-1057.
Crossref
Eleftherios Dalaveris, Theodora Kerenidi, Alexandra Katsabeki-Katsafli, Theodoros Kiropoulos, Kalliopi Tanou, Konstantinos I. Gourgoulianis & Konstantinos Kostikas. (2009) VEGF, TNF-α and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. Lung Cancer 64:2, pages 219-225.
Crossref
Zhong Cai, Qiuyan Chen, Jun Chen, Yi Lu, Guozhi Xiao, Zhihao Wu, Qinghua Zhou & Jian Zhang. (2009) Monocyte Chemotactic Protein 1 Promotes Lung Cancer?Induced Bone Resorptive Lesions In Vivo. Neoplasia 11:3, pages 228-236.
Crossref
Yong Ming Zhu, Nor Saadah M Azahri, Danny CW Yu & Penella J Woll. (2008) Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells. BMC Cancer 8:1.
Crossref
Takashi Muramatsu & Hisako Muramatsu. (2008) Glycosaminoglycan-binding cytokines as tumor markers. PROTEOMICS 8:16, pages 3350-3359.
Crossref
Huiyan Pan & Mustafa B. A. Djamgoz. (2008) Biochemical Constitution of Extracellular Medium is Critical for Control of Human Breast Cancer MDA-MB-231 Cell Motility. Journal of Membrane Biology 223:1, pages 27-36.
Crossref
Martin Kornacker, Angelika Roth, Olaf Christensen, Jörn Krätzschmar & Georg Wensing. (2008) Quantification of vascular endothelial growth factor, interleukin-8, and basic fibroblast growth factor in plasma of cancer patients and healthy volunteers – comparison of ELISA and microsphere-based multiplexed immunoassay. Clinical Chemistry and Laboratory Medicine 46:9.
Crossref
Ye-Sheng Wei, Yan Lan, Ren-Guang Tang, Qun-Qing Xu, Yan Huang, Hong-Bing Nong & Wei-Tong Huang. (2007) Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clinical Immunology 125:3, pages 309-317.
Crossref
Latha Shivakumar, David Lee, Aarati Ranganathan, David R. Gandara, Roy S. Herbst, Corey J. Langer & Primo N. LaraJrJr. (2007) 2007 Highlights from: the 12th World Conference on Lung Cancer Seoul, South Korea; September 2-6, 2007. Clinical Lung Cancer 8:9, pages 526-531.
Crossref
Clint Allen, Sonia Duffy, Theodoros Teknos, Mozaffarul Islam, Zhong Chen, Paul S. Albert, Gregory Wolf & Carter Van Waes. (2007) Nuclear Factor-κB–Related Serum Factors as Longitudinal Biomarkers of Response and Survival in Advanced Oropharyngeal Carcinoma. Clinical Cancer Research 13:11, pages 3182-3190.
Crossref
Christine L. Hann & Charles M. Rudin. (2007) Fast, hungry and unstable: finding the Achilles’ heel of small-cell lung cancer. Trends in Molecular Medicine 13:4, pages 150-157.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.